Brittany A. Irvine

Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes

Sheng Wei, J. Maciejewski, P. Fenaux, 2017, Haematologica.

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.

J. Cleveland, Sheng Wei, T. Cluzeau, 2016, Blood.

The Proinflammatory Protein S100A9 Suppresses Erythropoietin Elaboration in Patients with Myelodysplastic Syndromes

G. Mufti, Sheng Wei, J. Maciejewski, 2015 .

TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes

F. Solé, J. Maciejewski, T. Cluzeau, 2015, Oncotarget.

Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence

D. Krewski, N. Birkett, J. Gomes, 2017, Neurotoxicology.

Determinants of neurological disease: Synthesis of systematic reviews

J. Little, D. Krewski, Ming-dong Wang, 2017, Neurotoxicology.